Literature DB >> 2197999

Cytokine production in the rheumatoid joint: implications for treatment.

M Feldmann1, F M Brennan, D Chantry, C Haworth, M Turner, E Abney, G Buchan, K Barrett, D Barkley, A Chu.   

Abstract

Cytokines are protein mediators that play a part in inflammation, the immune response, cell growth, repair, and fibrosis. All of these are continuing processes in active rheumatoid arthritis (RA), and so it would be expected that many cytokines would be actively produced in RA joints. Here, the molecular strategies devised to study the possible role of cytokines in the pathogenesis of RA, are reviewed and some of the initial results described. The relative abundance of various cytokines is 'catalogued' and then attention is turned to an attempt to discover which cytokines are of major importance in the pathogenesis. Neutralising antibodies to cytokines were used for that purpose, and it was found that tumour necrosis factor alpha (TNF alpha) is one of the major signals regulating the production of interleukin-1 in the RA, but not in the osteoarthritic joint. To understand further the dynamics of the cytokine network localisation of the cytokine producing cells by immunostaining--for example, TNF alpha, is currently being established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197999

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  42 in total

1.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

Authors:  J A Quayle; F Watson; R C Bucknall; S W Edwards
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 4.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.

Authors:  William Bilsborough; Helen Keen; Andrew Taylor; Gerard J O'Driscoll; Leonard Arnolda; Daniel J Green
Journal:  Rheumatol Int       Date:  2006-06-24       Impact factor: 2.631

6.  Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction.

Authors:  S Wagner; P Fritz; H Einsele; S Sell; J G Saal
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

7.  Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis).

Authors:  A L Ramshaw; D E Roskell; D V Parums
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

8.  Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

Authors:  G D Anderson; S D Hauser; K L McGarity; M E Bremer; P C Isakson; S A Gregory
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis.

Authors:  F Watson; J J Robinson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

10.  The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes.

Authors:  M Kloppenburg; B M Brinkman; H H de Rooij-Dijk; A M Miltenburg; M R Daha; F C Breedveld; B A Dijkmans; C Verweij
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.